Sivalingam A - Search Results

Year	Number of Results
1989	1
1990	2
1991	5
1993	1
2000	2
2002	2
2003	2
2004	1
2007	1
2008	3
2011	2
2012	1
2014	4
2015	3
2016	4
2017	4
2018	3
2019	6
2020	5
2021	9
2022	8
2023	5
2024	19
2025	0

1

Khan MA, Sivalingam A, Haller JA. Khan MA, et al. Among authors: sivalingam a. Ophthalmol Retina. 2021 Apr;5(4):e6. doi: 10.1016/j.oret.2021.01.007. Ophthalmol Retina. 2021. PMID: 33814048 Free PMC article. No abstract available.

2

Reply.

Weiss SJ, Adam MK, Gao X, Obeid A, Sivalingam A, Fineman MS, Maguire JI, Garg SJ, Haller J, Fischer DH, Hsu J. Weiss SJ, et al. Among authors: sivalingam a. Retina. 2019 Aug;39(8):e38-e39. doi: 10.1097/IAE.0000000000002602. Retina. 2019. PMID: 31205274 No abstract available.

3

Reply.

Khan MA, Shahlaee A, Hsu J, Sivalingam A, Regillo CD, Ho AC, Toussaint B, Riemann CD, Dugel PU, Lakhanpal RR, Berrocal MH. Khan MA, et al. Among authors: sivalingam a. Am J Ophthalmol. 2016 Apr;164:145-6. doi: 10.1016/j.ajo.2016.02.010. Epub 2016 Mar 2. Am J Ophthalmol. 2016. PMID: 26944756 No abstract available.

4

Malaria in travelers: Childhood vaccination and focus on endemic regions.

Sivalingam AM, Pandian A, Ramasubbu R. Sivalingam AM, et al. Indian J Med Microbiol. 2024 May-Jun;49:100593. doi: 10.1016/j.ijmmb.2024.100593. Epub 2024 Apr 16. Indian J Med Microbiol. 2024. PMID: 38615989 No abstract available.

5

Idiopathic sclerochoroidal calcification.

Sivalingam A, Shields CL, Shields JA, McNamara JA, Jampol LM, Wood WJ, Daubert G. Sivalingam A, et al. Ophthalmology. 1991 May;98(5):720-4. doi: 10.1016/s0161-6420(91)32228-0. Ophthalmology. 1991. PMID: 2062507

6

Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.

Kymes SM, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, King J; SCORE2 Investigator Group. Kymes SM, et al. JAMA Ophthalmol. 2023 Jun 1;141(6):554-561. doi: 10.1001/jamaophthalmol.2023.1463. JAMA Ophthalmol. 2023. PMID: 37166820 Free PMC article.

7

Advances in understanding biomarkers and treating neurological diseases - Role of the cerebellar dysfunction and emerging therapies.

Sivalingam AM. Sivalingam AM. Ageing Res Rev. 2024 Nov;101:102519. doi: 10.1016/j.arr.2024.102519. Epub 2024 Sep 27. Ageing Res Rev. 2024. PMID: 39341507 Review.

8

Exploring Complication Risks and Innovations in Postweight Loss Recovery of Emerging Anti-obesity Medications.

Sivalingam AM, Pandian A, Manivel R. Sivalingam AM, et al. Obes Surg. 2024 Oct;34(10):3922-3923. doi: 10.1007/s11695-024-07496-8. Epub 2024 Sep 10. Obes Surg. 2024. PMID: 39254901 No abstract available.

9

New Perspectives on Sleeve Gastroplasty Trials for Patients with Autonomic and Hypothalamic Obesity.

Manivel R, Sivalingam AM. Manivel R, et al. Among authors: sivalingam am. Obes Surg. 2024 Oct;34(10):3911-3912. doi: 10.1007/s11695-024-07480-2. Epub 2024 Aug 22. Obes Surg. 2024. PMID: 39172290 No abstract available.

10

A comparative study of in vivo toxicity in zebrafish embryos synthesized CuO nanoparticles characterized from Salacia reticulata.

Sivalingam AM, Pandian A, Rengarajan S, Boopathy N, Selvaraj KRN. Sivalingam AM, et al. Environ Geochem Health. 2024 Jul 13;46(9):311. doi: 10.1007/s10653-024-02104-1. Environ Geochem Health. 2024. PMID: 39001930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year